Cue Biopharma (CUE) Selling, General & Administrative (2017 - 2026)
Cue Biopharma (CUE) reported Selling, General & Administrative of $46.57 million for Q2 2026, compared with $3.68 million a year earlier.
Powered by 
Analysis
Cue Biopharma (CUE) Selling, General & Administrative (2017 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Cue Biopharma's Selling, General & Administrative came in at $58.64 million, up 297.8% year-over-year; for FY2025, it was $16.24 million, up 11.4% from FY2024.
- Selling, General & Administrative has a five-year compound annual growth rate of 2.1% (FY2020 to FY2025).
- By year, Selling, General & Administrative came in at $14.59 million in FY2024 (-12.6%), $16.68 million in FY2023 (+3.2%), $16.17 million in FY2022 (-6.6%) and $17.31 million in FY2021 (+18.1%).
- The Q2 2026 figure ranks as the highest quarterly Selling, General & Administrative in data going back to Q1 2017.
- Year over year, Selling, General & Administrative gained in two of the last six quarters, with growth averaging 4.7%.
- The high point for year-over-year Selling, General & Administrative in five years was Q3 2025 (growth of 72.3%); the low point was Q3 2024 (a decline of 21.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,230.11 Bn | 1,198.70 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 644.39 Bn | 564.25 Bn | 17.30 Bn | 6.29 Bn |
| 3 | AbbVie | 503.52 Bn | 476.68 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 363.29 Bn | 317.72 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 298.23 Bn | 262.62 Bn | 11.24 Bn | 3.24 Bn |
| 6 | Astrazeneca | 267.53 Bn | 241.29 Bn | 12.86 Bn | 5.65 Bn |
| 7 | Amgen | 241.80 Bn | 197.20 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 195.07 Bn | 169.19 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 173.33 Bn | 120.28 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Cue Biopharma | 98.78 Mn | 8.05 Mn | - | 46.57 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 46.57 Mn |
| Dec 31, 2025 | 3.45 Mn |
| Sep 30, 2025 | 4.94 Mn |
| Jun 30, 2025 | 3.68 Mn |
| Mar 31, 2025 | 4.17 Mn |
| Dec 31, 2024 | 4.02 Mn |
| Sep 30, 2024 | 2.87 Mn |
| Jun 30, 2024 | 3.51 Mn |
| Mar 31, 2024 | 4.19 Mn |
| Dec 31, 2023 | 4.61 Mn |
| Sep 30, 2023 | 3.65 Mn |
| Jun 30, 2023 | 4.25 Mn |
| Mar 31, 2023 | 4.18 Mn |
| Dec 31, 2022 | 3.70 Mn |
| Sep 30, 2022 | 3.53 Mn |
| Jun 30, 2022 | 3.78 Mn |
| Mar 31, 2022 | 5.16 Mn |
| Dec 31, 2021 | 4.65 Mn |
| Sep 30, 2021 | 4.13 Mn |
| Jun 30, 2021 | 4.28 Mn |
API Access
Cue Biopharma Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=CUE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "CUE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=CUE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();